BA(English) BSc (Hons I Immunology) MBBS(Hons) PhD FRACP FRCPA
Sarah is a Clinical Immunologist/Immunopathologist and Scientia Senior Lecturer. She graduated from a BSc(HonsI)/BA (English) prior to a combined MBBS(Hons)/PhD program. Sarah completed specialist medical training in Clinical Immunology and Immunopathology at St Vincent's, Royal Prince Alfred, Concord, Liverpool and Campbelltown Hospitals and gained dual fellowships of the Royal Australasian College of Physicians and Royal College of Pathologists Australasia in 2017. From 2018-2019 Sarah undertook postdoctoral studies at the University of Oxford investigating autoimmune toxicities of immune checkpoint inhibitors in Professor Paul Klenerman's laboratory.
Sarah's broad research area is human translational Immunology. Her particular interests include the role of T cells in the control of cancers and sepsis as well as COVID-19 in immunocompromised people.
Broad Research Areas:
Immunology, Infectious Diseases, Cancer Immunology, Immune Checkpoint Inhibitors, Mucosal Immunology, Sepsis
BA, BSc(Hons I), MBBS(Hons), PhD, FRACP, FRCPA
2022-2026 MRFF for Comparing Immunisation-boosting Regimens for COVID-19 for people Upon Initiation of immunosuppressive Therapies ("CIRCUIT" RCT) (CIA)
2022-2026 MRFF for Comparing Use of B cell depletion therapies to IVIg in CIDP ("CUBIC" Study) (CIG)
2022-2023 NSW Health Pathology Grant for Critical Illness, Infection and Immunology "CI3" Biobank
2021-22 NIH R21 Co-infection and Cancer
2020-23 UNSW Scientia Fellowship
2020 Kirby Institute Emerging Investigator Award
2020 Australian Intensive Care Foundation Grant
2019 University of Oxford Human Immunology Discovery Initiative Grant
2019 University of Oxford Medical Sciences Division Pump-Prime Grant
2019 Nanostring Autoimmunity Grant
2018-19 Oxford-Celgene Postdoctoral Fellowship
2013 SydPath Research Grant
2006 NHMRC Dora Lush (Biomedical) PhD Scholarship
2004 St Vincent's Hospital Centre for Immunology PhD Scholarship
COVID-19 Outcomes Registry Study for Immunosuppressed Patients in Australia (CORIA) Study (2020)—Press Release
"First Cancer Immunology Ideas Forum Takes place at UNSW" (2021) —Article in 'Oncology Republic'
"Immunocompromised: The forgotten people" (2021)—Interview on 'The Briefing' Podcast
My Research Supervision